Metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways
ConclusionsThe results of this study will determine if the metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer mortality. It may provide the basis for targeting systemic insulin resistance and/or tumor insulin receptor signaling to reduce racial disparities in breast cancer mortality. This article is protected by copyright. All rights reserved.
Source: Diabetes/Metabolism Research and Reviews - Category: Endocrinology Authors: Emily J. Gallagher, Derek LeRoith, Rebeca Franco, Irini Markella Antoniou, Anupma Nayak, Jennifer Livaudais‐Toman, Nina Bickell Tags: Research Article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Insulin | Metabolic Syndrome | Nanotechnology | Obesity | Study | Women